Oct 12, 2020 2:45:00 AM

The Market Herald – Proteomics (ASX:PIQ) partners up with QIMR Berghofer Institute

“The blood test will help to improve the detection of oesophageal adenocarcinoma, Australia’s most common form of oesophageal cancer.“

“When offered to people who are predisposed to oesophageal cancer, the test may help reduce invasive, risky and expensive endoscopies.“

2020

Dr Richard Lipscombe, Managing Director of Proteomics International (ASX:PIQ), spoke with 2GB’s...

Proteomics International has topped up its coffers with a $2.16 million cash boost from Australia’s...

Proteomics International partners with QIMR Berghofer Medical Research Institute (QIMR Berghofer)...

Related posts